Medovex Financial Statements From 2010 to 2024
| HCYTDelisted Stock | USD 2.21 0.00 0.00% |
Check Medovex Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medovex Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medovex financial statements analysis is a perfect complement when working with Medovex Corp Valuation or Volatility modules.
Medovex |
Medovex Corp OTC Stock Operating Margin Analysis
Medovex Corp's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Medovex Corp Operating Margin | (3.51) % |
Most of Medovex Corp's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medovex Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Medovex Corp has an Operating Margin of -3.5065%. This is 90.0% lower than that of the Healthcare sector and 96.87% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 36.36% lower than that of the firm.
Medovex Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medovex Corp's current stock value. Our valuation model uses many indicators to compare Medovex Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medovex Corp competition to find correlations between indicators driving Medovex Corp's intrinsic value. More Info.Medovex Corp is rated below average in return on equity category among its peers. It is rated # 2 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medovex Corp's earnings, one of the primary drivers of an investment's value.About Medovex Corp Financial Statements
Medovex Corp shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Medovex Corp investors may analyze each financial statement separately, they are all interrelated. The changes in Medovex Corp's assets and liabilities, for example, are also reflected in the revenues and expenses on on Medovex Corp's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. H CYTE operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |